A recent literature showed that the activation of NLRP1 inflammasome and subsequent IL-18 production prevent obesity and metabolic syndrome, indicating that NLRP1/IL-18 axis prevents T2D and likely DN [35]. Here, IL18 is linked to obesity due to melanocortin 4 receptor deficiency.